May 24, 2011 (New York, New York) — The use of the combination therapy azilsartan medoxomil (Edarbi, Takeda Pharmaceuticals) and chlorthalidone resulted in a more effective reduction in systolic blood ...

February 25, 2011 (Updated February 28, 2011) (Silver Spring, Maryland) — The Food and Drug Administration (FDA) today approved a new angiotensin-receptor blocker (ARB), azilsartan medoxomil (Edarbi, ...

Deerfield, Ill., February 6, 2012 and Osaka, Japan, February 7, 2012 - Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda ...

MUMBAI, India and Naples, Fla., June 17, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the ...

Learn everything you need to know about Azilsartan Medoxomil-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

We investigated whether 10 mg per day of azilsartan, one-half of the normal dosage, would be non-inferior to 8 mg per day of candesartan cilexetil for controlling blood pressure in Japanese patients ...

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the US Food and Drug Administration (US FDA) to market Azilsartan Medoxomil and Chlorthalidone tablets, 40 mg/12.5 mg and 40 ...

Up-to-date prescription details regarding Azilsartan Medoxomil and Chlorthalidone are provided here. Understand it's uses, recommended dosages, its indications, how to take, when to take, when not to ...

Edarbi (azilsartan) is a high blood pressure medication that may cause side effects such as nausea and vomiting, fatigue, weakness, and cough. Some people may experience more significant side effects ...

Mumbai, 16th May, 2017 : Mankind Pharma, a quality driven pharmaceutical company in India launches Anti-Hypertensive-drug Zolahart (Azilsartan), at an affordable price of Rs 7.50 per tablet. Aiming at ...